Skip to main content

IRB Barcelona adapts its activity in the context of COVID-19



Press & Communications Section Head
Tel.+34 93 40 37255

Against the backdrop of the current health crisis, IRB Barcelona has been following the directives of the authorities to guarantee the health of its employees, to contribute to preventive measures to stop the spread of COVID-19, and to minimize the impact of these measures on the lines of research undertaken at the Institute. The aim is to guarantee minimum services and the maintenance of the Institute's research facilities and tools.

The work done by our computational scientists and many of the lab and administration tasks will continue to be undertaken. However, some projects have inevitably been suspended until things get back to normal and we can return to work. IRB Barcelona is working hard to keep on top of this situation, and we will get back to our cutting-edge science as soon circumstances permit.

As a research centre, we have made ourselves available to health authorities, putting our infrastructure, equipment and knowledge at the service of society. We will do everything in our power to contribute to the collective effort to fight this health crisis.

As research scientists, we want to contribute to the fight against COVID-19. In this respect, the Structural Bioinformatics and Network Biology laboratory, led by Patrick Aloy, is participating in the international project RiPCoN (funded by the European Commission). In addition, several IRB Barcelona groups are now preparing applications to the new calls from ISCII and EU that have just been announced.

We will continue to publish updates on our website so that you can stay abreast of developments. In the meantime, stay safe and look out for those around you.

IRB Barcelona is working on tackling the coronavirus pandemic: find out about our projects. 


About IRB Barcelona

The Institute for Research in Biomedicine (IRB Barcelona) pursues a society free of disease. To this end, it conducts multidisciplinary research of excellence to cure cancer and other diseases linked to ageing. It establishes technology transfer agreements with the pharmaceutical industry and major hospitals to bring research results closer to society, and organises a range of science outreach activities to engage the public in an open dialogue. IRB Barcelona is an international centre that hosts 400 researchers and more than 30 nationalities. Recognised as a Severo Ochoa Centre of Excellence since 2011, IRB Barcelona is a CERCA centre and member of the Barcelona Institute of Science and Technology (BIST).